The obesity epidemic and sexual health
New York, NY : Oxford University Press, 
An Interesting Case of Celiac Disease with Overlap with Other Autoimmune Conditions [Meeting Abstract]
A Case of a Co-infection with Blastocystis and Spirochetosis in an Immunocompetent Homosexual Male [Meeting Abstract]
Cardiovascular Effects of the New Weight Loss Agents
The global obesity epidemic and its impact on cardiovascular outcomes is a topic of ongoing debate and investigation in the cardiology community. It is well known that obesity is associated with multiple cardiovascular risk factors. Although life-style changes are the first line of therapy, they are often insufficient in achieving weight loss goals. Liraglutide, naltrexone/bupropion, and phentermine/topiramate are new agents that have been recently approved to treat obesity, but their effects on cardiovascular risk factors and outcomes are not well described. This review summarizes data currently available for these novel agents regarding drug safety, effects on major cardiovascular risk factors, impact on cardiovascular outcomes, outcomes research that is currently in progress, and areas of uncertainty. Given the impact of obesity on cardiovascular health, there is a pressing clinical need to understand the effects of these agents beyond weight loss alone.
Obesity and Hypogonadism
The relationship between obesity and hypogonadism is complicated. The relationship is bidirectional and there are numerous causative and correlative factors on both sides of the equation. Obesity is increasing in prevalence in epidemic proportions. Likewise, we are beginning to see the rapid increase in the incidence of male hypogonadism. It is only recently that we are learning the ways in which these 2 conditions exacerbate each other, and we are only beginning to understand how by treating one of these conditions, we can help to treat the other as well.
Your Guide to Making Prostate Cancer Treatment Decisions [General Interest Article]
Experts explain [General Interest Article]
Life after Prostate Cancer Treatment [General Interest Article]
Redefining prostate cancer : why one size does not fit all
Ann Arbor, MI : Spry Pub., 2013
Extent: 170 p. : ill. ; 23 cm.
No guts, no glory : gut solution, the core of your total wellness
Laguna Beach, CA : Basic Health Publications, c2012
Extent: 168 p. : ill. ; 23 cm.